Your browser doesn't support javascript.
loading
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
Soulie, Cathia; Santoro, Maria Mercedes; Storto, Alexandre; Abdi, Basma; Charpentier, Charlotte; Armenia, Daniele; Jary, Aude; Forbici, Federica; Bertoli, Ada; Gennari, William; Andreoni, Massimo; Mussini, Cristina; Antinori, Andrea; Perno, Carlo Federico; Calvez, Vincent; Ceccherini-Silberstein, Francesca; Descamps, Diane; Marcelin, Anne-Genevieve.
Afiliação
  • Soulie C; Sorbonne Université, INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
  • Santoro MM; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Storto A; Université de Paris, INSERM, UMR 1137 IAME, F-75018 Paris, France.
  • Abdi B; Sorbonne Université, INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
  • Charpentier C; Université de Paris, INSERM, UMR 1137 IAME, F-75018 Paris, France.
  • Armenia D; Laboratoire de Virologie, AP-HP, Hôpital Bichat-Claude Bernard, F-75018 Paris, France.
  • Jary A; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Forbici F; UniCamillus, Saint Camillus International University of Health Sciences, Rome, Italy.
  • Bertoli A; Sorbonne Université, INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
  • Gennari W; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
  • Andreoni M; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
  • Mussini C; Clinic of Infectious Diseases, Modena University Hospital, Modena, Italy.
  • Antinori A; Department of Clinical Infectious Diseases, University Hospital of Rome Tor Vergata, Rome, Italy.
  • Perno CF; Clinic of Infectious Diseases, Modena University Hospital, Modena, Italy.
  • Calvez V; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
  • Ceccherini-Silberstein F; National Institute for Infectious Diseases L. Spallanzani, IRCCS, Rome, Italy.
  • Descamps D; Sorbonne Université, INSERM, UMR_S 1136 Pierre Louis Institute of Epidemiology and Public Health, AP-HP, Hôpital Pitié Salpêtrière, Laboratoire de Virologie, Paris, France.
  • Marcelin AG; Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.
J Antimicrob Chemother ; 75(4): 1026-1030, 2020 04 01.
Article em En | MEDLINE | ID: mdl-31976534
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Europa Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França